Zenicor Medical Systems AB

ZENI · Nasdaq Stockholm · Healthcare

0.93SEK +2.8%last day

Price as of 1 October 2026

The price over the past year, with dividends: −38.7%

Performance

1 month

+2.2%

1 year

−38.7%

3 years, per year

−35.6%

5 years, per year

−48.3%

Largest fall, 3 years

−95.4%

Below the peak now

−97.9%

Volatility, 1 year

72.1%

Return with dividends reinvested.

Key figures

P/E

23.0

P/B

0.4

Dividend yield

0.0%

Return on equity

+1.8%

Net margin

+3.5%

Market value

2 m USD

Quality, value and trend

Where Zenicor Medical Systems stands against every Nordic stock today. 100 is best.

Quality39

Profitability and a sound balance sheet over time. Better than 39% of Nordic stocks.

Value90

The price measured against earnings, assets and cash flow. Better than 90% of Nordic stocks.

Trend15

The price development over the past year. Better than 15% of Nordic stocks.

Combined43

Quality, value and trend together. Better than 43% of Nordic stocks.

About Zenicor Medical Systems

Zenicor Medical Systems AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 20 employees.

Zenicor Medical Systems AB (publ), a medical technology company, develops systems and care chains for the diagnosis of arrhythmia and stroke prevention. The company offers Zenicor One, a handheld ECG device for arrhythmia; Zenicor Flex, a device that provides ECG data and arrhythmia detection; and Zenicor View, a web-based system solution for all types of arrhythmia investigations. It also provides Zenicor Direct, a solution with interpretation services and services for device logistics; and DeepRhythmAI, an AI technology of Zenicor Solution for modern arrhythmia diagnostics. The company was incorporated in 2003 and is headquartered in Stockholm, Sweden.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis